RAF1 and neoplasm: The proto-oncogene kinases BRAF and CRAF are well-documented HSP90 client proteins that have previously been shown to be ubiquitylated and degraded in tumor cell lines treated with the HSP90 inhibitor AUY922 (Sharp et al., 2007).